Answers are grounded in this paper and cite their sources.
Aim Temporal muscle thickness (TMT) has shown inconsistent prognostic utility in chronic subdural hematoma (cSDH). This study evaluated whether TMT independently predicted survival among surgically treated patients with cSDH while controlling for established clinical markers. Methods This is a 10-year single-center retrospective cohort study (2013-2023) that analyzed 105 patients aged ≥18 years who underwent surgical cSDH drainage at a tertiary center. Two independent neurosurgeons measured TMT on preoperative computed tomography scans, demonstrating excellent interrater reliability (intraclass correlation coefficients >0.9). TMT was adjusted for age and sex using linear regression in our cohort. Multivariate Cox regression identified independent predictors of mortality while controlling for traditional clinical markers. Results The mean age was 69.6±14.4 years with a mean TMT of 5.6±1.6 mm. Survival rates were 96.2% at 3 months and 63.7% at 60 months. In multivariate analysis, independent predictors of mortality included age [hazard ratio (HR)=1.06, p<0.005], albumin levels (HR=0.92, p=0.05; p=0.03 in the model without TMT), keyhole surgical technique (HR=0.18, p<0.005), living status (HR=2.58, p=0.04), and bilateral hematomas (HR=3.23, p=0.02). Temporal muscle thickness was not an independent predictor (HR=0.94, p=0.61). Conclusion TMT does not independently predict cSDH survival when traditional clinical markers are considered. Age, albumin levels, surgical technique, living status, and hematoma laterality remain stronger prognostic determinants than TMT alone.
No takes yet. Share an insight, caveat, or question.
Akbulut et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: